Skip to main content

RHUMBLINE ADVISERS

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 1115418 BOSTON, MA

Position in CRVS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,285,138
+$165,739 QoQ
Shares Held
86,020
+12.4% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 172 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority Sole 23% Shared 0% None 77%

Common Shares in CRVS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. CRVS ranks #119 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRVS

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,285,138 86,020
2026-03-31 $1,119,399 76,514
2025-12-31 $544,597 70,727
2025-09-30 $608,688 82,590
2025-06-30 $303,800 75,950
2024-09-30 $4,176 791
2024-06-30 $1,439 791
2024-03-31 $1,407 791
2023-12-31 $1,392 791
2023-09-30 $1,154 791
2023-06-30 $1,811 791